211 related articles for article (PubMed ID: 19767084)
41. Aspirin intolerance: does desensitization alter the course of the disease?
Klimek L; Pfaar O
Immunol Allergy Clin North Am; 2009 Nov; 29(4):669-75. PubMed ID: 19879442
[TBL] [Abstract][Full Text] [Related]
42. Intranasal ketorolac challenge for the diagnosis of aspirin-exacerbated respiratory disease.
White A; Bigby T; Stevenson D
Ann Allergy Asthma Immunol; 2006 Aug; 97(2):190-5. PubMed ID: 16937750
[TBL] [Abstract][Full Text] [Related]
43. [Expression of signal transducer and activator of transcription 6 in rat asthma model and the modulatory effect of dexamethasone].
Li CC; Ye LP; Chen XF; Li SB; Cai XH; Dong L; Luo YC; Zhang ZX
Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):521-5. PubMed ID: 16083555
[TBL] [Abstract][Full Text] [Related]
44. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases.
Katial RK; Strand M; Prasertsuntarasai T; Leung R; Zheng W; Alam R
J Allergy Clin Immunol; 2010 Oct; 126(4):738-44. PubMed ID: 20728206
[TBL] [Abstract][Full Text] [Related]
45. Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.
Stevenson DD; Mehra PK; White AA; Gupta S; Woessner KM; Simon RA
J Allergy Clin Immunol; 2005 Oct; 116(4):755-60. PubMed ID: 16210047
[TBL] [Abstract][Full Text] [Related]
46. Assessment of signal transducer and activator of transcription 6 as a target of glucocorticoid action in human airway epithelial cells.
Heller NM; Matsukura S; Georas SN; Boothby MR; Stellato C; Schleimer RP
Clin Exp Allergy; 2004 Nov; 34(11):1690-700. PubMed ID: 15544592
[TBL] [Abstract][Full Text] [Related]
47. Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-exacerbated Respiratory Disease. A Prospective Trial.
Cahill KN; Cui J; Kothari P; Murphy K; Raby BA; Singer J; Israel E; Boyce JA; Laidlaw TM
Am J Respir Crit Care Med; 2019 Sep; 200(6):704-711. PubMed ID: 30978291
[No Abstract] [Full Text] [Related]
48. Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells.
Katsuyama K; Shichiri M; Kato H; Imai T; Marumo F; Hirata Y
Endocrinology; 1999 May; 140(5):2183-90. PubMed ID: 10218970
[TBL] [Abstract][Full Text] [Related]
49. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper.
Macy E; Bernstein JA; Castells MC; Gawchik SM; Lee TH; Settipane RA; Simon RA; Wald J; Woessner KM;
Ann Allergy Asthma Immunol; 2007 Feb; 98(2):172-4. PubMed ID: 17304886
[TBL] [Abstract][Full Text] [Related]
50. Does suppression of IL-4 synthesis by aspirin explain the therapeutic benefit of aspirin desensitization treatment?
White AA; Stevenson DD
J Allergy Clin Immunol; 2010 Oct; 126(4):745-6. PubMed ID: 20920763
[No Abstract] [Full Text] [Related]
51. STAT6 phosphorylation inhibitors block eotaxin-3 secretion in bronchial epithelial cells.
Zhou L; Kawate T; Liu X; Kim YB; Zhao Y; Feng G; Banerji J; Nash H; Whitehurst C; Jindal S; Siddiqui A; Seed B; Wolfe JL
Bioorg Med Chem; 2012 Jan; 20(2):750-8. PubMed ID: 22217933
[TBL] [Abstract][Full Text] [Related]
52. STAT6 and JAK1 are essential for IL-4-mediated suppression of prostaglandin production in human follicular dendritic cells: opposing roles of phosphorylated and unphosphorylated STAT6.
Cho W; Jeoung DI; Kim YM; Choe J
Int Immunopharmacol; 2012 Apr; 12(4):635-42. PubMed ID: 22406175
[TBL] [Abstract][Full Text] [Related]
53. IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6.
Ohmori Y; Smith MF; Hamilton TA
J Immunol; 1996 Sep; 157(5):2058-65. PubMed ID: 8757327
[TBL] [Abstract][Full Text] [Related]
54. Aspirin-exacerbated respiratory disease: Prevalence, diagnosis, treatment, and considerations for the future.
Kennedy JL; Stoner AN; Borish L
Am J Rhinol Allergy; 2016 Nov; 30(6):407-413. PubMed ID: 28124651
[TBL] [Abstract][Full Text] [Related]
55. Histone H3k9 and H3k27 Acetylation Regulates IL-4/STAT6-Mediated Igε Transcription in B Lymphocytes.
Fu X; Wang X; Duan Z; Zhang C; Fu X; Yang J; Liu X; He J
Anat Rec (Hoboken); 2015 Aug; 298(8):1431-9. PubMed ID: 25952120
[TBL] [Abstract][Full Text] [Related]
56. Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma.
Adamjee J; Suh YJ; Park HS; Choi JH; Penrose JF; Lam BK; Austen KF; Cazaly AM; Wilson SJ; Sampson AP
J Pathol; 2006 Jul; 209(3):392-9. PubMed ID: 16583357
[TBL] [Abstract][Full Text] [Related]
57. Cellular allergen stimulation test with acetylsalicylic acid-lysine is not a useful test to discriminate between asthmatic patients with and without acetylsalicylic acid sensitivity.
Bavbek S; Dursun AB; Birben E; Kalayci O; Misirligil Z
Int Arch Allergy Immunol; 2009; 149(1):58-64. PubMed ID: 19033733
[TBL] [Abstract][Full Text] [Related]
58. Caffeic acid phenethyl ester suppresses eotaxin secretion and nuclear p-STAT6 in human lung fibroblast cells.
Lin YT; Hsu JY; Chen CJ; Chu JJ; Fu LS
J Microbiol Immunol Infect; 2011 Dec; 44(6):435-41. PubMed ID: 21601544
[TBL] [Abstract][Full Text] [Related]
59. Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis.
Schapowal AG; Simon HU; Schmitz-Schumann M
Acta Otorhinolaryngol Belg; 1995; 49(3):235-50. PubMed ID: 7484142
[TBL] [Abstract][Full Text] [Related]
60. Expression of the angiogenic factor thymidine phosphorylase in THP-1 monocytes: induction by autocrine tumor necrosis factor-alpha and inhibition by aspirin.
Zhu GH; Schwartz EL
Mol Pharmacol; 2003 Nov; 64(5):1251-8. PubMed ID: 14573775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
